Dapagliflozin Impurity 15
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

461432-23-5Dapagliflozin Impurity 15

● In Stock

Catalogue No.:VL1650013
CAS No.:461432-23-5
Mol. Formula:C15H14BrClO
Mol. Weight:325.63 g/mol

Additional information on CAS 461432-23-5

Parent drug

Dapagliflozin

IUPAC Name

4-Bromo-1-chloro-2-(4-ethoxybenzyl) benzene

Shipping Condition

Ambient Temperature

Synonyms

Dapagliflozin Despyranose Bromo Impurity; 4-Bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene;

Description

Dapagliflozin Impurity 15, also designated Dapagliflozin Despyranose Bromo Impurity, CAS 461432-23-5, is a halogenated process-related impurity associated with structural modification of the dapagliflozin scaffold through loss of the pyranose moiety and introduction of bromine. The compound has molecular formula C15H14BrClO and molecular weight 325.63 g/mol, indicating a lipophilic aromatic ether halide. Its occurrence is typically linked to synthetic intermediate carryover or halogenation side reactions during manufacture. Because such impurities can influence specification setting, profiling by LC-MS/MS, LC-HRMS, and orthogonal HPLC with UV or CAD detection is commonly required for definitive identification and quantification.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url